Strouhal Ondřej

Groups: ONCOLOGY

OLIVERIUS, M., D. FLAŠAROVÁ, B. MOHELNÍKOVÁ DUCHOŇOVÁ, M. EHRLICHOVA, V. HLAVAC, O. STROUHAL, P. DVORAK, I. OJIMA, P. SOUCEK

KRAS pathway expression changes in pancreatic cancer models by conventional and experimental taxanes. Mutagenesis. 2019, 34(5-6), 403-411, ISSN: 0267-8357, PMID: 31375828,

LOVECEK, M., M. JANATOVA, P. SKALICKÝ, T. ZEMÁNEK, R. HAVLÍK, J. EHRMANN, O. STROUHAL, P. ZEMANKOVA, K. LHOTOVA, M. BORECKA, J. SOUKUPOVA, H. ŠVÉBIŠOVÁ, P. SOUCEK, V. HLAVAC, Z. KLEIBL, C. NEORAL, B. MELICHAR, B. MOHELNÍKOVÁ DUCHOŇOVÁ

Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new potential hereditary genetic alterations. Cancer Management and Research. 2019, 11, 599-609, ISSN: 1179-1322, PMID: 30666157,

LEMSTROVÁ, R., V. BRYNYCHOVA, D. HUGHES, V. HLAVAC, P. DVORAK, J. DOHERTY, H. MURRAY, M. CROCKARD, M. OLIVERIUS, J. HLAVSA, E. HONSOVA, J. MAZANEC, Z. KALA, M. LOVEČEK, R. HAVLÍK, J. EHRMANN, O. STROUHAL, P. SOUCEK, B. MELICHAR, B. MOHELNÍKOVÁ DUCHOŇOVÁ

Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome. Oncology Letters. 2017, 8(1), 1236, ISSN: 1792-1074, PMID: 29089570,

Strouhal Ondřej

Journals